Tumor Treating Fields Mesothelioma, Pdf Emerging Treatments For Malignant Pleural Mesothelioma Where Are We Heading

Many in the mesothelioma treatment community are excited about tumor treating fields if only because its a new option for patients.

Eviction lawyers. It has been 15 years since the fda first approved the chemotherapy regimen of pemetrexed alimta with platinum therapy as the only standard option for patients. In vitro results and electric fields simulations suggest tumor treating fields ttfields to be an effective treatment against mesothelioma. We read with interest the study1 by giovanni ceresoli and colleagues testing tumour treating fields ttfields for inoperable malignant pleural mesothelioma.

The road to this new mesothelioma treatment has seen the completion of. Food and drug administration fda for approval later this year. Tumor treating fields is a cancer therapy that uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division.

Food and drug administration for treatment of malignant pleural mesothelioma. Proceedings of the 106th annual meeting of the american association for cancer research. Tumor treating fields is one of the newest treatments on the market for pleural mesothelioma cancer patients with metastatic disease.

In 2019 tumor treating fields became the second therapy approved by the us. Clinical trials of the treatment previously known as novottf 100l extended the survival of mesothelioma patients by more than six months. The fda has approved an electricity based mesothelioma treatment known as tumor treating fields novottf 100l.

This study on mesothelioma comes after other trials of ttfields in other advanced or recurrent tumours. A phase ii clinical trial occurring in different cancer institutes throughout europe is testing a novel malignant pleural mesothelioma cancer treatment involving the use of tumor treating fields or ttfieldsttfields are low intensity intermediate frequency electric fields that work to disrupt cancer cell growth and development by interacting with key molecules and proteins involved in the. It is the first new treatment for pleural mesothelioma since the approval of alimta pemetrexed in 2004.

Novocures commercialized products are approved for the treatment of adult patients with glioblastoma and malignant pleural mesothelioma. The device is also available to patients with locally advanced cancer who are not candidates for mesothelioma surgery. Ttfields is an anti tumour technology delivering low intensity electric fields that interfere with mitosis.

April 1822 2015 abstr 5361. Food and drug administrations approval is explicitly for people with pleural mesothelioma a cancer that forms in the thin protective lining between the lung cavity and chest wall.